Reverse DCF
What growth does the market imply for INDOAMIN?
Working backwards from the current price to find the FCF growth assumption baked in.
unrealistic
60.0% implied annual FCF growth
The market is pricing in hyper-growth that virtually no established company has sustained for 10 years. This implies either a structural disruption scenario or significant overvaluation.
Current Price
₹131
Historical Growth
7.4%
FCF Yield
0.04%
Price / FCF
2636.8x
Plain English
To justify today's price of ₹131.32, INDOAMIN.NS needs to grow its free cash flow at 60.0% per year for the next 10 years. That is 52.6% faster than its historical growth rate of 7.4%. At its historical growth rate, the stock cannot justify its current price within a 20-year horizon. The market is pricing in a step-change in performance.
Adjust Assumptions
Growth Scenarios
What the stock is worth at different growth assumptions
| Scenario | FCF Growth | Implied IV | MoS vs Price |
|---|---|---|---|
| Historical | 7.4% | ₹0 | -100.0% |
| GDP rate | 10.0% | ₹0 | -100.0% |
| Half implied | 30.0% | ₹0 | -100.0% |
| Implied | 60.0% | ₹131 | +0.0% |
At Historical Growth Rate
DCF horizon: 10 years. At 7.4% growth, the model values INDOAMIN at ₹0, below today's ₹131.
See full DCF analysis
Bear/base/bull scenarios, sensitivity heatmap, reverse DCF, and more.
Run Full Analysis →This is an analytical tool, not investment advice. Implied growth is a mathematical inversion of the DCF model and depends on WACC and terminal growth assumptions. YieldIQ is not registered with SEBI as an investment adviser.